Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
May 15, 2020

Hologic receives EUA for Covid-19 assay

By Chloe Kent

Hologic has received Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) for its Aptima SARS-CoV-2 assay.

The antigen test runs on Hologic’s fully automated Panther system, which can provide initial results within three hours and carry out over 1,000 Covid-19 tests within a 24-hour period.

The test was the first Covid-19 diagnostic to receive R&D support from the US government Biomedical Advanced Research and Development Authority (BARDA), receiving nearly $700,000 in funding.

Hologic plans to register its Aptima SARS-CoV-2 assay for a CE Mark for diagnostic use in Europe later in May.

Related Companies

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy